Ruxolitinib

Sort by

Ruxolitinib R-isomer

  • CAT NUMBER DCTI-C-2396
  • CAS NUMBER 941678-49-5
  • MOLECULAR FORMULA C17H18N6
  • MOLECULAR WEIGHT 306.37

Ruxolitinib RXP-03-Urea

  • CAT NUMBER DCTI-C-3041
  • CAS NUMBER NA
  • MOLECULAR FORMULA C18H19N7O
  • MOLECULAR WEIGHT 349.4

Ruxolitinib SEM pyrimidine Impurity/RXPI

  • CAT NUMBER DCTI-C-2397
  • CAS NUMBER 941685-27-4
  • MOLECULAR FORMULA C15H21N5OSi
  • MOLECULAR WEIGHT 315.45

Ruxolitinib Triphenyl phosphine oxide

  • CAT NUMBER DCTI-C-2398
  • CAS NUMBER 791-28-6
  • MOLECULAR FORMULA C18H15OP
  • MOLECULAR WEIGHT 278.29

Ruxolitinib-D9

  • CAT Number DCTI-A-142
  • CAS Number 941678-49-5(Unlabelled)
  • Molecular Formula C17H9D9N6
  • Molecular Weight 315.43
LOAD MORE
You're viewed all 14 products
References
FAQ's

Frequently Asked Questions

The factors influencing the synthesis of Ruxolitinib impurities include the choice of starting materials, reaction conditions, solvent choice, temperature, and catalysts.

The degradation impurities in Ruxolitinib may include impurities formed due to chemical or physical degradation of the drug, such as hydrolysis, oxidation, and photodegradation.

Analytical techniques such as high-performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS), etc., help identify and quantify Ruxolitinib impurities.

Ruxolitinib impurities are isolated and purified using techniques, column chromatography, recrystallization, and preparative HPLC.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart